Dendreon Pharmaceuticals LLC

CA · United States · Reporting entity ID 100000196774

Total reported 2019–2025

$16.3M

#363 of 2,960 reporting companies — 0% of all reported industry payments

$4.32M in general payments across 56,598 records, plus $12.0M in research funding across 1,913 records.

How it breaks down

General payments $4,319,800

Research funding $12,001,253

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.